Pfizer Inc. is a global biopharmaceutical company incorporated in Delaware and headquartered in New York, New York, with common stock listed on the New York Stock Exchange under the ticker PFE. The company develops, manufactures, and commercializes medicines and vaccines across a broad range of therapeutic areas through its Biopharma reportable segment, which generated $44,056 million in revenues for the nine months ended September 28, 2025. Pfizer also earns alliance revenues from co-promotion agreements and royalty revenues, with total revenues of $45,022 million for the nine-month period ended September 28, 2025 [Source: 10-Q, filed 2025-11-04, Condensed Consolidated Statements of Operations and Segment disclosures].

What is PFE's DredgeCap risk score?

DredgeCap's AI analysis rates PFE at 3.8/10 on the risk scale — Low risk. This score reflects dilution exposure, debt toxicity, liquidity position, and going-concern posture as disclosed in SEC filings.

Does PFE have a going concern warning?

No current auditor going-concern warning is flagged in PFE's SEC filings. Risk assessment is based on other filing-disclosed factors.

When did PFE last file with the SEC?

PFE's most recent SEC filing was a 10-K filed 2026-02-26. All filings are available on SEC EDGAR.

← PFE Overview

8-KMay 5, 2026

PFE — 8-K Filing

Track PFE for Alerts

8-K Items Disclosed

Item 2.02 — Results of Operations and Financial Condition

Quarterly or annual earnings results released. Often paired with a press release as Exhibit 99.1.

Item 9.01 — Financial Statements and Exhibits

Press releases, exhibits, and supporting documents attached to this filing.

PFE Filing Excerpt

pfe-20260505 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGE ACT OF 1934Date of Report (Date of earliest event reported): May 5, 2026PFIZER INC.(Exact name of registrant as specified in its charter)Delaware1-361913-5315170(State or other(Commission File(I.R.S. Employerjurisdiction ofNumber)Identification No.)incorporation) 66 Hudson Boulevard East10001-2192New York, New York (Zip Code)(Address of principal executive offices)Registrant’s telephone number, including area code:(212) 733-2323 (Former name or former address, if changed since last report)Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))☐ Pre-commencement communications pursuant to Rule…

Current DredgeCap Risk Profile

Risk Score

3.8/10

MODERATE

Dilution

2.0

Debt Toxicity

3.5

Going Concern

✓ Not flagged

The risk profile above reflects the latest cached DredgeCap analysis for PFE. For the full filing-by-filing analyst report (red flags, primary risk driver, what moves the stock), open PFE's company page.

What is a 8-K?

A current report disclosing a material event that occurred between regular reporting periods. Companies are required to file an 8-K within four business days of certain events including earnings releases, executive changes, acquisitions, debt obligations, restructurings, and material agreements. Each 8-K specifies one or more 'Items' identifying which event triggered the filing.

More on PFE

The plain-language summary above is composed mechanically from the filing's reported numbers — no analysis or opinion. Form-type explainers and 8-K item descriptions are derived from SEC documentation. This page does not constitute investment advice. Always consult the original filing on SEC EDGAR for authoritative content, and consult a licensed financial advisor for investment decisions.